Shionogi (TSE:4507) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4507 Shionogi & Co Ltd TSE:4507
90 GF Score
Price 円3,070.00
GF Value 円3,017.20
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Shionogi Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

TSE:4507
90GF Score
Shionogi & Co Ltd TSE:4507
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shionogi (TSE:4507) Overvalued in 2026?

Based on GuruFocus' analysis, Shionogi stock appears to be overvalued. The current stock price of 円3,070.00 is trading 1.7% above its estimated GF Value™ of 円3,017.20. GuruFocus considers Shionogi to be Fairly Valued.

Key valuation signals for TSE:4507:

  • Dividends Received:
  • GF Value™: 円3,017.20 vs. price of 円3,070.00 (1.7% above fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the TSE:4507 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shionogi Business Description

Address 3-1-8 Doshomachi, Chuo-ku, Osaka, JPN, 541-0045
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. The company engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late-stage drug discovery through commercial production. It provides products and services in Japan, Europe, North America, and other regions.
90GF Score

Get the complete analysis for TSE:4507

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,070.00
Price
円3,017.20
GF Value